JP2016536318A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016536318A5 JP2016536318A5 JP2016528894A JP2016528894A JP2016536318A5 JP 2016536318 A5 JP2016536318 A5 JP 2016536318A5 JP 2016528894 A JP2016528894 A JP 2016528894A JP 2016528894 A JP2016528894 A JP 2016528894A JP 2016536318 A5 JP2016536318 A5 JP 2016536318A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- metal
- nanoscale particles
- lipid
- nanoscale
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002105 nanoparticle Substances 0.000 claims 22
- 108020004707 nucleic acids Proteins 0.000 claims 17
- 150000007523 nucleic acids Chemical class 0.000 claims 17
- 102000039446 nucleic acids Human genes 0.000 claims 17
- 150000002632 lipids Chemical class 0.000 claims 7
- 239000011159 matrix material Substances 0.000 claims 7
- 229940122361 Bisphosphonate Drugs 0.000 claims 6
- 108020004459 Small interfering RNA Proteins 0.000 claims 6
- 239000002246 antineoplastic agent Substances 0.000 claims 6
- 150000004663 bisphosphonates Chemical class 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 6
- 229940124597 therapeutic agent Drugs 0.000 claims 6
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 239000011248 coating agent Substances 0.000 claims 4
- 239000011247 coating layer Substances 0.000 claims 4
- 229940127089 cytotoxic agent Drugs 0.000 claims 4
- 239000002184 metal Substances 0.000 claims 4
- 229910021645 metal ion Inorganic materials 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 201000011510 cancer Diseases 0.000 claims 3
- 102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 claims 2
- 239000000232 Lipid Bilayer Substances 0.000 claims 2
- 206010033128 Ovarian cancer Diseases 0.000 claims 2
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 2
- 230000003796 beauty Effects 0.000 claims 2
- 125000002091 cationic group Chemical group 0.000 claims 2
- -1 cationic lipid Chemical class 0.000 claims 2
- 229940044683 chemotherapy drug Drugs 0.000 claims 2
- 239000013256 coordination polymer Substances 0.000 claims 2
- 229920001795 coordination polymer Polymers 0.000 claims 2
- 239000004530 micro-emulsion Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 2
- 229940002612 prodrug Drugs 0.000 claims 2
- 239000000651 prodrug Substances 0.000 claims 2
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 claims 1
- 102100021663 Baculoviral IAP repeat-containing protein 5 Human genes 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 claims 1
- 101100226013 Mus musculus Ercc1 gene Proteins 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 108010002687 Survivin Proteins 0.000 claims 1
- 238000002512 chemotherapy Methods 0.000 claims 1
- 229960004316 cisplatin Drugs 0.000 claims 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 230000009881 electrostatic interaction Effects 0.000 claims 1
- 239000012216 imaging agent Substances 0.000 claims 1
- 239000013554 lipid monolayer Substances 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229910044991 metal oxide Inorganic materials 0.000 claims 1
- 150000004706 metal oxides Chemical class 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 108091070501 miRNA Proteins 0.000 claims 1
- 239000002679 microRNA Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 claims 1
- 229960001756 oxaliplatin Drugs 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims 1
- 239000003504 photosensitizing agent Substances 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 229940126585 therapeutic drug Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361900698P | 2013-11-06 | 2013-11-06 | |
| US61/900,698 | 2013-11-06 | ||
| PCT/US2014/064388 WO2015069926A1 (en) | 2013-11-06 | 2014-11-06 | Nanoscale carriers for the delivery or co-delivery of chemotherapeutics, nucleic acids and photosensitizers |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019167976A Division JP2020011974A (ja) | 2013-11-06 | 2019-09-17 | 化学療法用薬剤、核酸及び光増感剤の送達又は共送達のためのナノスケール輸送体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016536318A JP2016536318A (ja) | 2016-11-24 |
| JP2016536318A5 true JP2016536318A5 (enExample) | 2017-12-14 |
| JP6590802B2 JP6590802B2 (ja) | 2019-10-16 |
Family
ID=53042088
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016528894A Active JP6590802B2 (ja) | 2013-11-06 | 2014-11-06 | 化学療法用薬剤、核酸及び光増感剤の送達又は共送達のためのナノスケール輸送体 |
| JP2019167976A Pending JP2020011974A (ja) | 2013-11-06 | 2019-09-17 | 化学療法用薬剤、核酸及び光増感剤の送達又は共送達のためのナノスケール輸送体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019167976A Pending JP2020011974A (ja) | 2013-11-06 | 2019-09-17 | 化学療法用薬剤、核酸及び光増感剤の送達又は共送達のためのナノスケール輸送体 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US10517822B2 (enExample) |
| EP (1) | EP3065713B1 (enExample) |
| JP (2) | JP6590802B2 (enExample) |
| CN (1) | CN105873569B (enExample) |
| WO (1) | WO2015069926A1 (enExample) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6049712B2 (ja) | 2011-07-08 | 2016-12-21 | ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒルＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｎｏｒｔｈ Ｃａｒｏｌｉｎａ Ａｔ Ｃｈａｐｅｌ Ｈｉｌｌ | 抗癌治療及び画像化並びに骨障害治療のための金属ビスホスホネートナノ粒子 |
| WO2014066834A1 (en) * | 2012-10-26 | 2014-05-01 | The University Of Chicago | Synergistic combination of immunologic inhibitors for the treatment of cancer |
| WO2015149068A1 (en) | 2014-03-28 | 2015-10-01 | The University Of Chicago | Chiral ligand-based metal-organic frameworks for broad-scope asymmetric catalysis |
| US10647733B2 (en) | 2014-03-28 | 2020-05-12 | The University Of Chicago | Metal-organic frameworks containing nitrogen-donor ligands for efficient catalytic organic transformations |
| US10806694B2 (en) | 2014-10-14 | 2020-10-20 | The University Of Chicago | Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, chemotherapy, immunotherapy, and any combination thereof |
| EP3206987B2 (en) | 2014-10-14 | 2024-07-24 | The University of Chicago | Nanoparticles for photodynamic therapy, x-ray induced photodynamic therapy, radiotherapy, chemotherapy, immunotherapy, and any combination thereof |
| AU2015230812A1 (en) * | 2015-09-25 | 2017-04-13 | The University Of Sydney | Treatment and prevention of adrenocortical carcinoma |
| US10953393B2 (en) | 2015-10-12 | 2021-03-23 | The University Of Chicago | Stabilization of active metal catalysts at metal-organic framework nodes for highly efficient organic transformations |
| WO2017192573A1 (en) | 2016-05-02 | 2017-11-09 | Massachusetts Institute Of Technology | Nanoparticle conjugates of highly potent toxins and intraperitoneal administration of nanoparticles for treating or imaging cancer |
| EP3439666A4 (en) * | 2016-05-20 | 2019-12-11 | The University of Chicago | NANOPARTICLES FOR CHEMOTHERAPY, TARGETED THERAPY, PHOTODYNAMIC THERAPY, IMMUNOTHERAPY AND ALL COMBINATIONS THEREOF |
| EP3474987A4 (en) | 2016-08-18 | 2020-01-08 | The University of Chicago | METAL CATALYSTS SUPPORTED BY A METAL OXIDE AND ABUNDANT IN THE EARTH FOR HIGHLY EFFICIENT ORGANIC TRANSFORMATIONS |
| WO2018067431A1 (en) * | 2016-10-03 | 2018-04-12 | Purdue Research Foundation | Re-sensitizing drug-resistant cancer cells by combinational therapy |
| CN108318311B (zh) * | 2017-01-15 | 2022-01-18 | 复旦大学 | 一种硬骨特异性钙质荧光染色方法及其应用 |
| CN106947010B (zh) * | 2017-04-06 | 2018-12-11 | 哈尔滨工业大学 | 一种利用光引发raft聚合原位诱导自组装制备蛋白质基纳米粒子的方法 |
| CN107142281A (zh) * | 2017-06-07 | 2017-09-08 | 东华大学 | 聚酰胺‑胺树状大分子与纳米金颗粒的复合物作为非病毒载体进行基因转染的应用方法 |
| CN111194232B (zh) * | 2017-08-02 | 2023-01-31 | 芝加哥大学 | 纳米级金属有机层和金属有机纳米片 |
| CN109554397A (zh) * | 2017-09-26 | 2019-04-02 | 广州宏柯源生物科技有限公司 | 纳米颗粒及其制备方法 |
| CN107753946B (zh) * | 2017-10-23 | 2020-11-27 | 福州大学 | 一种适配体修饰的靶向载药纳米粒及其制备方法与应用 |
| GB201717975D0 (en) * | 2017-10-31 | 2017-12-13 | Cambridge Entpr Ltd | Metal organic framework-based compositions and uses thereof |
| CN111526857B (zh) * | 2017-12-21 | 2023-07-04 | H&A帕玛科株式会社 | 利用金属-有机骨架材料和纳米纤维素的用于透皮递送的复合物 |
| US20190314324A1 (en) | 2018-04-13 | 2019-10-17 | The University Of Chicago | Combination of micheliolide derivatives or nanoparticles with ionizing radiation and checkpoint inhibitors for cancer therapy |
| CN108619511B (zh) * | 2018-04-20 | 2020-12-15 | 山东大学 | 一种基于阿糖胞苷小分子前药的金属有机框架载药系统的制备方法和应用 |
| CN108794532A (zh) * | 2018-05-18 | 2018-11-13 | 东北林业大学 | 脑磷脂类似物、制备方法及用途 |
| CN111110846B (zh) * | 2018-10-30 | 2021-07-23 | 国家纳米科学中心 | 一种金属-核酸纳米颗粒及其制备方法和用途 |
| CN111139234B (zh) * | 2018-11-06 | 2022-02-01 | 举康(上海)生物科技有限公司 | 一种游离dna提取试剂盒 |
| EA202191315A1 (ru) | 2018-11-09 | 2021-09-08 | Арбутус Биофарма Корпорэйшн | Катионные липиды, содержащие кремний |
| US20220177494A1 (en) * | 2019-04-08 | 2022-06-09 | Wisconsin Alumni Research Foundation | pH-RESPONSIVE SILICA METAL ORGANIC FRAMEWORK NANOPARTICLES FOR DELIVERY OF BIOACTIVE MOLECULES |
| CN110201160B (zh) * | 2019-05-20 | 2021-12-03 | 广东医科大学 | 锆金属有机骨架化合物的制备方法 |
| CN110862546B (zh) * | 2019-10-12 | 2021-07-09 | 厦门大学 | 一种甲氨蝶呤金属配位聚合物及其制备方法和应用 |
| WO2021097194A1 (en) * | 2019-11-14 | 2021-05-20 | Board Of Regents, The University Of Texas System | Compositions and methods for controlled delivery and protection of therapeutic agents |
| WO2021237209A1 (en) * | 2020-05-22 | 2021-11-25 | The University Of Chicago | Metal-organic frameworks deliver small molecules and biomacromolecules for cancer immunotherapy |
| AU2021312696A1 (en) * | 2020-07-23 | 2023-02-09 | Jack Coleman | Fluorescence quencher polymer conjugates and uses thereof |
| CN115998862B (zh) * | 2021-10-21 | 2025-07-11 | 北京化工大学 | 肿瘤特异性酶响应的光动力治疗纳米材料及其制备与应用 |
| CN114099706B (zh) * | 2021-11-30 | 2024-10-01 | 江南大学 | 一种用于乳腺癌治疗的mof药物载体及其制备方法 |
| CN114748644B (zh) * | 2022-05-20 | 2023-08-18 | 齐齐哈尔大学 | 一种以zif-8为基质的藻蓝蛋白分子印迹药物载体的制备方法 |
| CN115501202B (zh) * | 2022-10-12 | 2023-05-19 | 北京大学 | 一种递送过渡态唾液酸转移酶抑制剂的核壳纳米粒子及其制备方法和应用 |
| CN115449088B (zh) * | 2022-10-28 | 2023-06-16 | 中国人民解放军陆军特色医学中心 | 一种高孔隙cof纳米颗粒及其制备方法和作为药物载体的应用 |
| CN116212050B (zh) * | 2023-03-20 | 2025-08-08 | 浙江大学 | 一种小分子化疗药/生物大分子/金属有机框架复合材料的制备方法及其产品和应用 |
| CN117138055B (zh) * | 2023-06-02 | 2024-04-16 | 中山大学附属第一医院 | 一种双载体的阿霉素载药纳米材料及其制备方法 |
| CN116808235A (zh) * | 2023-06-27 | 2023-09-29 | 安徽瑞拜药业有限公司 | 一种核酸载体及其制备方法 |
Family Cites Families (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL61351A (en) | 1980-10-27 | 1983-12-30 | Yeda Res & Dev | Organometallic polymers,their preparation and compositions of co-ordination compounds containing them |
| US5147806A (en) | 1988-04-29 | 1992-09-15 | Igen, Inc. | Method and apparatus for conducting electrochemiluminescence measurements |
| US5213788A (en) | 1988-09-29 | 1993-05-25 | Ranney David F | Physically and chemically stabilized polyatomic clusters for magnetic resonance image and spectral enhancement |
| CA2086527A1 (en) | 1990-07-26 | 1992-01-27 | Samuel J. Tremont | Polymeric drug delivery system |
| US6013638A (en) | 1991-10-02 | 2000-01-11 | The United States Of America As Represented By The Department Of Health And Human Services | Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung |
| US5858784A (en) | 1991-12-17 | 1999-01-12 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol- and liposome-based delivery |
| US5871710A (en) | 1992-09-04 | 1999-02-16 | The General Hospital Corporation | Graft co-polymer adducts of platinum (II) compounds |
| US5591730A (en) | 1993-10-12 | 1997-01-07 | The Regents Of The University Of California | Inhibition of urinary calculi growth |
| US20010003647A1 (en) | 1995-06-07 | 2001-06-14 | Ji Sun | Coreatant-including electrochemiluminescent compounds, methods, systems and kits utilizing same |
| US5641623A (en) | 1995-01-04 | 1997-06-24 | Martin; Mark T. | Electrochemiluminescence assay |
| US6022737A (en) | 1995-11-02 | 2000-02-08 | Amgen Inc. | Formulations for non-viral in vivo transfection in the lungs |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| ATE236188T1 (de) | 1997-01-24 | 2003-04-15 | Conpharma As | Gemcitabin-derivate |
| US6180082B1 (en) | 1997-11-24 | 2001-01-30 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Method to enhance tissue accumulation of radiolabeled compounds |
| US6984400B2 (en) | 1998-07-14 | 2006-01-10 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Method of treating restenosis using bisphosphonate nanoparticles |
| US6602932B2 (en) | 1999-12-15 | 2003-08-05 | North Carolina State University | Nanoparticle composites and nanocapsules for guest encapsulation and methods for synthesizing same |
| CA2405360A1 (en) | 2000-04-07 | 2001-10-18 | The Board Of Regents Of The University Of Texas System | Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced gi toxicity |
| US6548264B1 (en) | 2000-05-17 | 2003-04-15 | University Of Florida | Coated nanoparticles |
| JP2004517619A (ja) | 2000-12-21 | 2004-06-17 | ノバルティス アクチエンゲゼルシャフト | インターロイキン−１関連遺伝子およびタンパク質 |
| CA2499977A1 (en) | 2002-09-28 | 2004-04-08 | Mcneil-Ppc, Inc. | Edible solid composition and dosage form |
| WO2004041203A2 (en) | 2002-11-04 | 2004-05-21 | Xenoport, Inc. | Gemcitabine prodrugs, pharmaceutical compositions and uses thereof |
| KR100401335B1 (en) | 2003-03-08 | 2003-10-10 | Mijitech Co Ltd | Metal nanoparticle surface-coated with silicon oxides and preparation thereof |
| US6878838B2 (en) | 2003-03-24 | 2005-04-12 | The University Of North Carolina At Chapel Hill | Chiral porous metal phosphonates for heterogeneous asymmetric catalysis |
| WO2004084871A1 (en) | 2003-03-26 | 2004-10-07 | Ltt Bio-Pharma Co., Ltd. | Intravenous nanoparticles for targenting drug delivery and sustained drug release |
| WO2004089345A1 (en) | 2003-04-03 | 2004-10-21 | Semafore Pharmaceuticals Inc. | Bone targeting of biodegradable drug-containing nanoparticles |
| AU2004261243A1 (en) | 2003-07-31 | 2005-02-10 | 3M Innovative Properties Company | Bioactive compositions comprising triazines |
| US20050147963A1 (en) | 2003-12-29 | 2005-07-07 | Intel Corporation | Composite organic-inorganic nanoparticles and methods for use thereof |
| FR2874016B1 (fr) | 2004-06-30 | 2006-11-24 | Centre Nat Rech Scient Cnrse | Nanoparticules de derives de la gemcitabine |
| US20070218049A1 (en) | 2006-02-02 | 2007-09-20 | Wei Chen | Nanoparticle based photodynamic therapy and methods of making and using same |
| JP4992091B2 (ja) | 2005-02-17 | 2012-08-08 | ハダシット メディカル リサーチ サービシーズ アンド デベロップメント リミテッド | 子宮内膜症を治療するためのビスホスホネート |
| CN1305937C (zh) | 2005-02-25 | 2007-03-21 | 复旦大学 | 一种金属配位聚合物纳米结构材料的制备方法 |
| EP1865928A1 (en) | 2005-03-17 | 2007-12-19 | Elan Pharma International Limited | Nanoparticulate biphosphonate compositions |
| NO322682B1 (no) | 2005-03-18 | 2006-11-27 | Clavis Pharma Asa | Anvendelse av gemcitabinderivater for fremstilling av orale doseringsformer ved kreftbehandling, samt slike orale doseringsformer |
| PE20070360A1 (es) | 2005-09-01 | 2007-04-19 | Novartis Ag | Composiciones de liposomas |
| US20080095699A1 (en) * | 2006-10-20 | 2008-04-24 | Shiying Zheng | Imaging contrast agents using nanoparticles |
| US20070088161A1 (en) | 2005-10-19 | 2007-04-19 | Stockel Richard F | Novel chelated bisphosphonates for use as pharmaceutical agents |
| US20090242856A1 (en) | 2006-02-09 | 2009-10-01 | Simon Fraser University | Birefringent metal-containing coordination polymers |
| KR100943923B1 (ko) | 2006-03-17 | 2010-02-24 | 홍순해 | 킬레이팅 유기 고분자와 생물학적 금속으로 이루어진 나노입자, 그리고 ｅｐｒ 효과를 이용한 새로운 광범위 무독성항암제 및 그 제조 방법 |
| US20090317335A1 (en) | 2006-04-20 | 2009-12-24 | Wenbin Lin | Hybrid Nanomaterials as Multimodal Imaging Contrast Agents |
| WO2008016172A1 (fr) | 2006-08-04 | 2008-02-07 | Kurume University | Inhibiteur de métastase |
| US20080124281A1 (en) | 2006-11-29 | 2008-05-29 | Board Of Regents, The University Of Texas System | Nanotubular probes as ultrasensitive mr contrast agent |
| US8146682B2 (en) | 2007-04-04 | 2012-04-03 | Weatherford/Lamb, Inc. | Apparatus and methods of milling a restricted casing shoe |
| WO2008124639A2 (en) | 2007-04-04 | 2008-10-16 | Massachusetts Institute Of Technology | Poly (amino acid) targeting moieties |
| US8486452B2 (en) | 2007-07-20 | 2013-07-16 | Mylan Pharmaceuticals Inc. | Stabilized tolterodine tartrate formulations |
| FR2921838A1 (fr) | 2007-10-05 | 2009-04-10 | Guerbet Sa | Nouveau procede de preparation de nanoparticules recouvertes d'une couche stabilisatrice gem-bisphosphonate couplee a des ligands de biodistribution hydrophile |
| WO2009139939A2 (en) | 2008-02-22 | 2009-11-19 | The University Of North Carolina At Chapel Hill | Hybrid nanoparticles as anti-cancer therapeutic agents and dual therapeutic/imaging contrast agents |
| WO2009114476A1 (en) | 2008-03-12 | 2009-09-17 | Intradigm Corporation | Compositions comprising survivin sirna and methods of use thereof |
| GB0807862D0 (en) | 2008-04-29 | 2008-06-04 | Uni I Oslo | Compounds |
| US20100221329A1 (en) | 2008-12-03 | 2010-09-02 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase c agonists and methods of use |
| WO2010140986A1 (en) | 2009-06-05 | 2010-12-09 | Nanyang Technological University | Targetted drug delivery to the bone |
| EP2488206B1 (en) | 2009-10-16 | 2018-03-21 | University Health Network (UHN) | Porphyrin nanovesicles |
| AU2010322516A1 (en) | 2009-11-20 | 2012-05-17 | Clavis Pharma Asa | Parenteral formulations of gemcitabine derivatives |
| GB201013307D0 (en) * | 2010-08-09 | 2010-09-22 | Univ St Andrews | Anti-microbial metal organic framework |
| IT1401882B1 (it) | 2010-10-01 | 2013-08-28 | Rosa De | Nanoparticelle autoassemblanti per il rilascio di bifosfonati nel trattamento di tumori. |
| US20120301537A1 (en) | 2011-05-23 | 2012-11-29 | Delta-Fly Pharma, Inc. | LIPOSOME CONTAINING shRNA MOLECULE TARGETING A THYMIDYLATE SYNTHASE AND USE THEREOF |
| JP6076968B2 (ja) * | 2011-06-06 | 2017-02-08 | ユニバーシティ・ヘルス・ネットワーク | ポルフィリン−リン脂質コンジュゲートを合成する方法 |
| EP2721032A4 (en) | 2011-06-16 | 2014-11-05 | Univ South Florida | POLYHEDRIC CAGE WITH METAL OPORPHYRENE EQUIPMENT, METHOD FOR THE PRODUCTION THEREOF AND METHOD FOR THEIR USE |
| EP2541220B1 (de) | 2011-06-28 | 2015-04-08 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Vorrichtung zur Messung einer Temperatur eines Leistungshalbleiters |
| EP2540321A1 (en) | 2011-06-30 | 2013-01-02 | Bayer Intellectual Property GmbH | Bis Tridentate W3O2 Clusters for X-Ray imaging |
| JP6049712B2 (ja) | 2011-07-08 | 2016-12-21 | ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒルＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｎｏｒｔｈ Ｃａｒｏｌｉｎａ Ａｔ Ｃｈａｐｅｌ Ｈｉｌｌ | 抗癌治療及び画像化並びに骨障害治療のための金属ビスホスホネートナノ粒子 |
| CN102432654A (zh) | 2011-09-26 | 2012-05-02 | 宋云龙 | 吉西他滨酰胺衍生物及其制备方法和用途 |
| WO2013068965A2 (en) | 2011-11-11 | 2013-05-16 | Koninklijke Philips Electronics N.V. | Lighting apparatus and manufacturing method for manufacturing the lighting apparatus |
| US10647733B2 (en) | 2014-03-28 | 2020-05-12 | The University Of Chicago | Metal-organic frameworks containing nitrogen-donor ligands for efficient catalytic organic transformations |
| WO2015149068A1 (en) | 2014-03-28 | 2015-10-01 | The University Of Chicago | Chiral ligand-based metal-organic frameworks for broad-scope asymmetric catalysis |
-
2014
- 2014-11-06 WO PCT/US2014/064388 patent/WO2015069926A1/en not_active Ceased
- 2014-11-06 EP EP14860910.0A patent/EP3065713B1/en active Active
- 2014-11-06 CN CN201480072258.0A patent/CN105873569B/zh active Active
- 2014-11-06 US US15/034,799 patent/US10517822B2/en active Active
- 2014-11-06 JP JP2016528894A patent/JP6590802B2/ja active Active
-
2019
- 2019-09-17 JP JP2019167976A patent/JP2020011974A/ja active Pending
- 2019-09-20 US US16/577,818 patent/US20200085742A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016536318A5 (enExample) | ||
| JP2019523757A5 (enExample) | ||
| Pavelić et al. | Nanoparticles in medicine: current status in cancer treatment | |
| Krasteva et al. | Promising therapeutic strategies for colorectal cancer treatment based on nanomaterials | |
| Al Bostami et al. | Recent advances in nanoparticle-based co-delivery systems for cancer therapy | |
| Ibrahim et al. | Encapsulation, release, and cytotoxicity of doxorubicin loaded in liposomes, micelles, and metal-organic frameworks: a review | |
| Correa et al. | Solution conditions tune and optimize loading of therapeutic polyelectrolytes into layer-by-layer functionalized liposomes | |
| Balachandran et al. | Integrated microfluidic synthesis of aptamer functionalized biozeolitic imidazolate framework (BioZIF-8) targeting lymph node and tumor | |
| Demir Duman et al. | Glycopolymer-functionalized MOF-808 nanoparticles as a cancer-targeted dual drug delivery system for carboplatin and floxuridine | |
| Jan et al. | Biomimetic cell membrane‐coated poly (lactic‐co‐glycolic acid) nanoparticles for biomedical applications | |
| Sabit et al. | Nanocarriers: a reliable tool for the delivery of anticancer drugs | |
| Tarn et al. | Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility | |
| Basilotta et al. | Role of calixarene in chemotherapy delivery strategies | |
| Soe et al. | Transferrin-conjugated polymeric nanoparticle for receptor-mediated delivery of doxorubicin in doxorubicin-resistant breast cancer cells | |
| Hao et al. | One-step synthesis of amine-functionalized hollow mesoporous silica nanoparticles as efficient antibacterial and anticancer materials | |
| Li et al. | Mesoporous silica nanoparticles coated by layer-by-layer self-assembly using cucurbit [7] uril for in vitro and in vivo anticancer drug release | |
| Wang et al. | Amphiphilic polymer-mediated formation of laponite-based nanohybrids with robust stability and pH sensitivity for anticancer drug delivery | |
| Florczak et al. | Silk particles as carriers of therapeutic molecules for cancer treatment | |
| DK2621539T3 (en) | SELECTIVE NANOPARTICLES FOR RELEASE OF BISPHOSPHONATES FOR TREATMENT OF HUMAN CANCERS | |
| Tong et al. | Research status and prospect of non-viral vectors based on siRNA: a review | |
| Zhu et al. | Journey to the market: the evolution of biodegradable drug delivery systems | |
| Zhang et al. | Advanced applications of DNA nanostructures dominated by DNA origami in antitumor drug delivery | |
| JP2016529284A5 (enExample) | ||
| Argenziano et al. | Developing actively targeted nanoparticles to fight cancer: Focus on italian research | |
| JP2014513135A5 (enExample) |